headlines

Drug industry disaster concerns prompted lab expansion says Intertek

iStock/ronniechua

Drug industry concerns about natural disasters are driving demand for ‘storage-only’ stability testing according to Intertek, which has announced plans to expand its UK lab.

Consultant Anders Fuglsang: "Which pharma company would ever subcontract a partner without a QMS?" (iStock/Duncan_Andison)

US ban for Changzhou Jintan Qianyao raises questions about customers says expert

Recro Gainesville is an FDA- and DEA-approved solid oral dose manufacturing services provider. (Image: iStock/dolgachov)

CDMO Recro expands manufacturing capabilities at former Alkermes site

iStock/daboost

Granules India confirms $35m US plant expansion will create jobs

iStock/ia_64

Eye drops to replace painful injections in AMD patients

iStock/almir1968

US FDA rejects Sun epilepsy drug due to ongoing problems at Halol plant

Image: iStock/anyaivanova

Looking to the long-term: Serialisation regulations here to stay, Tracelink

iStock/olm26250

EMA proposal concerns: “Public health trumps commercial confidentiality”

iStock/ImageDB

DSM Sinochem wins patent infringement ruling against Sinopharm Weiqida

iStock/Nostal6ie

US FDA warns liquid drug firms to test for Burkholderia cepacia

See More headlines